Ferro R - Search Results

1

Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer.

Emmanouilidi A, Fyffe CA, Ferro R, Edling CE, Capone E, Sestito S, Rapposelli S, Lattanzio R, Iacobelli S, Sala G, Maffucci T, Falasca M. Emmanouilidi A, et al. Among authors: ferro r. J Exp Clin Cancer Res. 2019 May 14;38(1):191. doi: 10.1186/s13046-019-1191-2. J Exp Clin Cancer Res. 2019. PMID: 31088502 Free PMC article.

2

GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine.

Ferro R, Adamska A, Lattanzio R, Mavrommati I, Edling CE, Arifin SA, Fyffe CA, Sala G, Sacchetto L, Chiorino G, De Laurenzi V, Piantelli M, Sansom OJ, Maffucci T, Falasca M. Ferro R, et al. Oncogene. 2018 Dec;37(49):6368-6382. doi: 10.1038/s41388-018-0390-1. Epub 2018 Jul 30. Oncogene. 2018. PMID: 30061636

3

Emerging role of the KRAS-PDK1 axis in pancreatic cancer.

Ferro R, Falasca M. Ferro R, et al. World J Gastroenterol. 2014 Aug 21;20(31):10752-7. doi: 10.3748/wjg.v20.i31.10752. World J Gastroenterol. 2014. PMID: 25152578 Free PMC article. Review.

4

Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.

Chikh A, Ferro R, Abbott JJ, Piñeiro R, Buus R, Iezzi M, Ricci F, Bergamaschi D, Ostano P, Chiorino G, Lattanzio R, Broggini M, Piantelli M, Maffucci T, Falasca M. Chikh A, et al. Among authors: ferro r. Oncotarget. 2016 Apr 5;7(14):18325-45. doi: 10.18632/oncotarget.7761. Oncotarget. 2016. PMID: 26934321 Free PMC article.

5

ABCC3 is a novel target for the treatment of pancreatic cancer.

Adamska A, Ferro R, Lattanzio R, Capone E, Domenichini A, Damiani V, Chiorino G, Akkaya BG, Linton KJ, De Laurenzi V, Sala G, Falasca M. Adamska A, et al. Among authors: ferro r. Adv Biol Regul. 2019 Aug;73:100634. doi: 10.1016/j.jbior.2019.04.004. Epub 2019 Apr 24. Adv Biol Regul. 2019. PMID: 31053501

6

Role of the lysophosphatidylinositol/GPR55 axis in cancer.

Falasca M, Ferro R. Falasca M, et al. Among authors: ferro r. Adv Biol Regul. 2016 Jan;60:88-93. doi: 10.1016/j.jbior.2015.10.003. Epub 2015 Oct 28. Adv Biol Regul. 2016. PMID: 26588872 Review.

7

A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion.

Raimondi C, Calleja V, Ferro R, Fantin A, Riley AM, Potter BV, Brennan CH, Maffucci T, Larijani B, Falasca M. Raimondi C, et al. Among authors: ferro r. Sci Rep. 2016 May 20;6:26142. doi: 10.1038/srep26142. Sci Rep. 2016. PMID: 27199173 Free PMC article.

8

Lysophosphatidylinositol: a novel link between ABC transporters and G-protein-coupled receptors.

Ruban EL, Ferro R, Arifin SA, Falasca M. Ruban EL, et al. Among authors: ferro r. Biochem Soc Trans. 2014 Oct;42(5):1372-7. doi: 10.1042/BST20140151. Biochem Soc Trans. 2014. PMID: 25233417 Review.

9

CD31 signals confer immune privilege to the vascular endothelium.

Cheung K, Ma L, Wang G, Coe D, Ferro R, Falasca M, Buckley CD, Mauro C, Marelli-Berg FM. Cheung K, et al. Among authors: ferro r. Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):E5815-24. doi: 10.1073/pnas.1509627112. Epub 2015 Sep 21. Proc Natl Acad Sci U S A. 2015. PMID: 26392551 Free PMC article.

10

Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance.

Tarantino D, Walker C, Weekes D, Pemberton H, Davidson K, Torga G, Frankum J, Mendes-Pereira AM, Prince C, Ferro R, Brough R, Pettitt SJ, Lord CJ, Grigoriadis A, Nj Tutt A. Tarantino D, et al. Among authors: ferro r. Oncogene. 2022 Aug;41(32):3969-3977. doi: 10.1038/s41388-022-02369-9. Epub 2022 Jun 29. Oncogene. 2022. PMID: 35768547 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page